An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain

Not Applicable

Completed

• Conditions: Chronic Pain
• Interventions: Other: medication reviews, assessment, recommendations, education.

• Registration Number: NCT03087331
• Lead Sponsor: University of Waterloo

Brief Summary

This is a prospective, pre post, pilot cohort study to be conducted in patients with chronic pain, which is defined as pain that lasts beyond 3 months. To accomplish the primary and secondary objectives of the study, three phrases will be designed and completed during three months

Detailed Description

This study will evaluate the effectiveness of community-based pharmacist interventions on the quality of life of patients with chronic pain as determined by self-reported pain levels using an established scoring system. Participating pharmacists will enroll chronic pain patients from their normal practice to receive a consultation, which consists of an assessment of their current pain, a medication review, and education about their condition. Based on the information provided by the patient, the pharmacist will prepare a care plan, contact the patient's prescriber, and, in conjunction with the prescriber, implement the plan to help relieve their pain. Follow-up assessments will be done after 2 weeks, and 3 months.

Study Timeline

• Study Start: 2016-02
• Study First Submitted: 2016-05-10
• Study First Submitted QC: 2017-03-15
• Study First Posted: 2017-03-22
• Primary Completion: 2017-05
• Study Completion: 2017-05
• Status Verified: 2017-11
• Last Update Submitted: 2017-11-15
• Last Update Posted: 2017-11-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 19

Inclusion Criteria

1. Aged 18 or older
2. Baseline average pain intensity using Brief Pain Inventory is 6 or higher
3. Ambulatory and able to attend the intervention
4. Complaining of pain for 3 months or longer

Exclusion Criteria

1. Patients with malignant or cancer pain
2. Patients who are unable to communicate in English
3. Non-ambulatory and unable to attend the intervention at the participating site
4. Unable to give informed consent.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Pharmacist intervention	medication reviews, assessment, recommendations, education.	Within the pharmacist intervention arm, pharmacists will do medication reviews, assessment, recommendations, education.

Primary Outcome Measures

Name	Time	Method
Pain intensity change	baseline, 2 weeks follow-up, 3 months follow-up	Pain intensity will be measured with Brief Pain Inventory pain intensity subscale, and will be measured 3 times in total

Secondary Outcome Measures

Name	Time	Method
Pain interference	baseline, 2 weeks follow-up, 3 months follow-up	Pain interference will be measured with Brief Pain Inventory pain interference subscale, and will be measured 3 times in total
Quality of life change	baseline, 3 months follow-up	quality of life will be measured using Short Form-36, and will be measured twice in total.

Trial Locations

Locations (1)

The PharmaShoppe; 🇨🇦 Kitchener, Ontario, Canada